SCHEMBL5477084

SCHEMBL5477084

CC(C)(C)C(CCn1cc(-c2ccnc3c2cc(-c2cccc(CO)c2)n3S(=O)(=O)c2ccccc2)c(-c2ccc([N+](=O)[O-])cc2)n1)NC(=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGDR2 Q9Y5Y4 1/20 0.36
▸ AURKA O14965 11/20 0.34
▸ AURKB Q96GD4 11/20 0.34
▸ ADAMTS4 O75173 2/20 0.33
▸ AR P10275 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ PTGS2 P35354 1/20 0.32
▸ PLK4 O00444 1/20 0.32
▸ CIT O14578 1/20 0.32
▸ EPHB6 O15197 1/20 0.32
▸ RIPK2 O43353 1/20 0.32
▸ ROCK2 O75116 1/20 0.32
▸ PRKD3 O94806 1/20 0.32
▸ MAP4K4 O95819 1/20 0.32
▸ NTRK1 P04629 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5477093 1.00 PTGDR2 (0.36) PTGDR2AURKAAURKBADAMTS4AR
SCHEMBL5477159 0.90 AURKA (0.40) PTGDR2AURKAAURKBARPLK4
SCHEMBL5477155 0.90 AURKA (0.40) PTGDR2AURKAAURKBARPLK4
SCHEMBL4312403 0.87 PTGDR2 (0.38) PTGDR2AURKAAURKBARMEN1
SCHEMBL4316715 0.87 AURKA (0.41) PTGDR2AURKAAURKBMEN1LMNA
SCHEMBL4312400 0.85 PTGDR2 (0.37) PTGDR2AURKAAURKBARMEN1
SCHEMBL4312396 0.85 PTGDR2 (0.37) PTGDR2AURKAAURKBARMEN1
SCHEMBL5477095 0.85 PTGDR2 (0.37) PTGDR2AURKAAURKBARMEN1
SCHEMBL5477089 0.84 AURKA (0.35) PTGDR2AURKAAURKBARMEN1
SCHEMBL4316683 0.81 AURKA (0.40) PTGDR2AURKAAURKBMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7282588-B2 Azaindole inhibitors of aurora kinases SMITHKLINE BEECHAM (US) 2007-10-16 — — US disclosed
US-20070149561-A1 AZAINDOLE INHIBITORS OF AURORA KINASES GLAXOSMITHKLINE LLC 2007-06-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070149561-A1 AZAINDOLE INHIBITORS OF AURORA KINASES AURKA, AURKC, AURKB PTGDR2 4533/4885AURKA 1/4885AURKB 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback